1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for France
Angioedema Treatment Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in France Angioedema
Treatment Market
4.
France Angioedema Treatment
Market by Drugs Type
4.1.
C1 Esterase Inhibitor
4.1.1. Cinryze
4.1.2. Berinert
4.1.3. Ruconest
4.1.4. Haegarda
4.2.
Selective Bradykinin B2 Receptor Antagonist
4.2.1. Firazyr
4.3.
Kallikrein Inhibitor
4.3.1. Kalbitor
5.
France Angioedema Treatment
Market by Route of Administration
5.1.
Oral
5.2.
Injections
6.
France Angioedema Treatment
Market by End-user
6.1.
Hospitals
6.2.
Clinics
6.3.
Research Organizations
7.
Company Profiles
7.1.
Manufacturer's & Suppliers
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.1.4. Company 4
7.1.5. Company 5
7.2.
Dealer's / Distributor's Profile
7.2.1. Dealer's /
Distributor's 1
7.2.2. Dealer's /
Distributor's 2
7.2.3. Dealer's /
Distributor's 3
7.2.4. Dealer's /
Distributor's 4
7.2.5. Dealer's /
Distributor's 5
7.2.6. Dealer's /
Distributor's 6
7.2.7. Dealer's /
Distributor's 7
7.2.8. Dealer's /
Distributor's 8
7.2.9. Dealer's /
Distributor's 9
7.2.10.
Dealer's / Distributor's 10
1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for France
Angioedema Treatment Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in France Angioedema
Treatment Market
4.
France Angioedema Treatment
Market by Drugs Type
4.1.
C1 Esterase Inhibitor
4.1.1. Cinryze
4.1.2. Berinert
4.1.3. Ruconest
4.1.4. Haegarda
4.2.
Selective Bradykinin B2 Receptor Antagonist
4.2.1. Firazyr
4.3.
Kallikrein Inhibitor
4.3.1. Kalbitor
5.
France Angioedema Treatment
Market by Route of Administration
5.1.
Oral
5.2.
Injections
6.
France Angioedema Treatment
Market by End-user
6.1.
Hospitals
6.2.
Clinics
6.3.
Research Organizations
7.
Company Profiles
7.1.
Manufacturer's & Suppliers
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.1.4. Company 4
7.1.5. Company 5
7.2.
Dealer's / Distributor's Profile
7.2.1. Dealer's /
Distributor's 1
7.2.2. Dealer's /
Distributor's 2
7.2.3. Dealer's /
Distributor's 3
7.2.4. Dealer's /
Distributor's 4
7.2.5. Dealer's /
Distributor's 5
7.2.6. Dealer's /
Distributor's 6
7.2.7. Dealer's /
Distributor's 7
7.2.8. Dealer's /
Distributor's 8
7.2.9. Dealer's /
Distributor's 9
7.2.10.
Dealer's / Distributor's 10